Allianz Asset Management GmbH

Position in ARWR — Arrowhead Pharmaceuticals, Inc.

CIK 1535323 MUNICH, 2M

Position in ARWR

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$4,542,633

+$1,055,134 QoQ

Shares Held

55,731

+0.2% QoQ

Ownership

0.039%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#136

of 497 holders

Holding Since

Mar 2020

13 quarters on record

Voting authority Sole 25% Shared 0% None 75%

Healthcare · as of Jun 30, 2026

Allianz Asset Management GmbH holds $690,566,615 across 64 Biotechnology names. ARWR ranks #20 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	327,683	$204,323,456
2	JAZZ	Jazz Pharmaceuticals plc	564,696	$136,074,794
3	MRNA	Moderna, Inc.	989,897	$69,322,486
4	EXEL	Exelixis, Inc.	853,093	$46,416,787
5	APGE	Apogee Therapeutics, Inc.	179,500	$23,825,035
6	BMRN	Biomarin Pharmaceutical Inc	400,036	$22,890,059
7	FTRE	Fortrea Holdings Inc.	1,127,337	$19,615,663
8	ACAD	Acadia Pharmaceuticals Inc	706,664	$17,878,599

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,542,633	55,731	+0.2%	Shares	Defined	2026-08-14
2026-03-31	$3,487,499	55,622	+194.3%	Shares	Defined	2026-05-11
2025-12-31	$1,254,771	18,900	+83.5%	Shares	Defined	2026-02-11
2025-09-30	$355,247	10,300	-30.5%	Shares	Defined	2025-11-04
2022-03-31	$681,295	14,814	-64.8%	Shares	Defined	2022-05-13
2021-12-31	$2,790,699	42,092	+52.2%	Shares	Defined	2022-02-11
2021-09-30	$1,726,813	27,660	+1.1%	Shares	Defined	2021-11-10
2021-06-30	$2,265,209	27,351	-19.1%	Shares	Defined	2021-08-16
2021-03-31	$2,241,476	33,803	-51.5%	Shares	Defined	2021-05-13
2020-12-31	$5,350,766	69,735	+479.1%	Shares	Defined	2021-02-16
2020-09-30	$518,571	12,043	+6.4%	Shares	Defined	2020-11-13
2020-06-30	$488,694	11,315	+6.9%	Shares	Defined	2020-08-14
2020-03-31	$304,501	10,584	—	Shares	Defined	2020-05-14
No filing history on record for this holder in this stock.